Prostate Cancer remains a top priority for health systems around the world as incidence level rises, fueled by growing and aging populations. The main drivers for the prostate cancer market are the increase in the global aging population, innovation in drugs and developments in genomics and proteomics. The prostate cancer market faces some hindrances as well such as the high cost of prostate cancer drugs, low success rate of clinical trials and side effects of treatments among others.
Browse the Full Report @ http://www.orbisresearch.com/reports/index/global-prostate-cancer-therapeutics-market-to-2020 .
Global Prostate Cancer – Key Therapies Analysis: The global market for prostate cancer therapeutics is increasing, driven primarily by the growth in the hormonal therapy markets. Chemotherapy was the second leading therapy for prostate cancer in 2014. However, growth in the targeted therapy is predicted to push chemotherapy back at the third position, while immunotherapy for prostate cancer stands at the last position in the prostate cancer therapeutics market.
Prostate Cancer Drugs Analysis: Zytiga leads the prostate cancer drugs market in 2014. Zytiga is facing stiff competition from Xtandi drugs which is expected to replace Zytiga as the leading prostate cancer drugs. In prostate cancer drugs market, Leuplin and Zoladex stands at the third and fourth position in 2014. The market share of both Leuplin and Zoladex is likely to plunge during the forecasting period. Lupron is standing at the fifth position. Bayer’s targeted therapy drugs Xofigo is also rapidly catching up the market due to advantages such as increase in the overall survival and progression free survival with benign side effects profile.
Check the Discount for this Report @ http://www.orbisresearch.com/contacts/discount/175257 .
iGATE RESEARCH report titled Global Prostate Cancer Therapeutics Market to 2020 is a 76 page report with 43 Figures and 4 Tables. This report analyses the Prostate Cancer Therapy Market, Prostate Cancer Drugs Market, driving factors and challenges for prostate cancer market.
The 4 Prostate Cancer Therapy Market covered in the report are as follows:
Request a Sample of this Report @ http://www.orbisresearch.com/contacts/request-sample/175257 .
Some Points from List Of Table :
Table 4-1: Global – Prostate Cancer Therapy Market Share (Percent), 2011 – 2014
Table 4-2: Global – Forecast for Prostate Cancer Therapy Market Share (Percent), 2015 – 2020
Table 4-3: Global – Prostate Cancer Drugs Market Share (Percent), 2011 – 2014
Table 4-4: Global – Forecast for Prostate Cancer Drugs Market Share (Percent), 2015 – 2020
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019